Related references
Note: Only part of the references are listed.Oral Nucleoside/Nucleotide Analogs Without Hepatitis B Immune Globulin After Liver Transplantation for Hepatitis B
James Fung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B
Robert Perrillo et al.
LIVER TRANSPLANTATION (2013)
Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis
Manav Wadhawan et al.
LIVER TRANSPLANTATION (2013)
Efficacy of Entecavir With or Without Tenofovir Disoproxil Fumarate for Nucleos(t)ide-Naive Patients With Chronic Hepatitis B
Anna S. Lok et al.
GASTROENTEROLOGY (2012)
The option of HBIG-free prophylaxis against recurrent HBV
Alyson N. Fox et al.
JOURNAL OF HEPATOLOGY (2012)
Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation
James Fung et al.
GASTROENTEROLOGY (2011)
Hepatitis B Immunoglobulin and/or Nucleos(t)ide Analogues for Prophylaxis Against Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review
Evangelos Cholongitas et al.
LIVER TRANSPLANTATION (2011)
Prophylaxis Against Hepatitis B Recurrence Posttransplantation Using Lamivudine and Individualized Low-Dose Hepatitis B Immunoglobulin
L. Jiang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Clearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma in a Cohort Chronically Infected with Hepatitis B Virus
Josephine Simonetti et al.
HEPATOLOGY (2010)
被撤回的出版物: Prevention and Risk Factors of the HBV Recurrence After Orthotopic Liver Transplantation: 160 Cases Follow-Up Study (Retracted article. See vol. 103, pg. 1736, 2019)
Shi-Bin Xie et al.
TRANSPLANTATION (2010)
Antiviral Resistance and Hepatitis B Therapy
Marc G. Ghany et al.
HEPATOLOGY (2009)
Side Effects of Long-Term Oral Antiviral Therapy for Hepatitis B
Robert J. Fontana
HEPATOLOGY (2009)
The role of entecavir in preventing hepatitis B recurrence after liver transplantation
Zhi Feng Xi et al.
JOURNAL OF DIGESTIVE DISEASES (2009)
Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation
Hyun Young Woo et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis
Murat Akyildiz et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Presence of intrahepatic (Total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation
Munira Hussain et al.
LIVER TRANSPLANTATION (2007)
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results
Eugene Schiff et al.
LIVER TRANSPLANTATION (2007)
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation
Edward J. Gane et al.
GASTROENTEROLOGY (2007)
Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B immunoglobulin prophylaxis
SS Zheng et al.
LIVER TRANSPLANTATION (2006)
Outcome of liver transplantation for hepatitis B in the United States
WR Kim et al.
LIVER TRANSPLANTATION (2004)
Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions
R Schilling et al.
JOURNAL OF VIROLOGY (2003)
HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis
B Roche et al.
HEPATOLOGY (2003)
Prophylaxis and treatment of recurrent hepatitis B after liver transplantation
CM Lo et al.
TRANSPLANTATION (2003)
Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease
T Steinmüller et al.
HEPATOLOGY (2002)
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis
RP Perrillo et al.
HEPATOLOGY (2001)
Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis
CM Lo et al.
ANNALS OF SURGERY (2001)
Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: A concise review
D Shouval et al.
HEPATOLOGY (2000)
An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy
SHB Han et al.
LIVER TRANSPLANTATION (2000)
Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B
PW Angus et al.
LIVER TRANSPLANTATION (2000)
Share Paper
